Melanoma

From the Field

Anticipated Cost Savings with Alternate Dosing Schema of Nivolumab/Ipilimumab for the Treatment of Metastatic Melanoma

08/20/2021

Allison Kupsh, PharmD

Laura Alwan, PharmD

Eve Segal, PharmD

Kate Trieselmann, PharmD

Evan Hall, MD

Allison Kupsh, PharmD, and colleagues found that the anticipated cost of NIVO3+IPI1 for the treatment of metastatic melanoma may be lower compared when compared with NIVO1+IPI3, amounting to over $1,000,000 in total savings.

Allison Kupsh, PharmD, and...

08/20/2021

Journal of Clinical Pathways

News

Cutaneous AEs Mild, Manageable With Immune Checkpoint Inhibitors for Melanoma

07/16/2020

Cutaneous adverse events (AEs) from anti-CTLA4 and anti-PD1 combination therapy for metastatic melanoma are mostly mild and can be managed using topical steroids and/or oral histamines, according to a study published...

...

07/16/2020

Journal of Clinical Pathways

Online Exclusive

When A Suspected Granuloma Turns Out To Be Acral Lentiginous Melanoma

11/01/2019

By Bret Brennan, DPM and Britni Sklencar, DPM

By Bret Brennan, DPM and Britni Sklen...

Acral lentiginous melanoma can be particularly difficult to diagnose in the nail, as it classically presents as a black-brown longitudinal band typical of longitudinal melanonychia. However, these authors note with this case study that...

Acral lentiginous melanoma can...

11/01/2019

Podiatry Today

Case Report

CASE REPORT Nodular Melanoma in an African American Female

10/04/2019

Vincent Brown, MD,a Tom Reisler, BSc(Hons), MB ChB, MRCS(Ed),b and Jake Laks, MDa

Vincent Brown, MD,a Tom Reisler, BSc(...

CASE REPORT Nodular Melanoma in an African American Female Vincent Brown, MD,a Tom Reisler, BSc(Hons), MB ChB, MRCS(Ed),b and Jake Laks, MDa aDepartment of Surgery, The Brody School of Medicine, East Carolina University,...

CASE REPORT Nodular...

10/04/2019

ePlasty

Case Report and Brief Review

Misdiagnosed Malignant Tumor on an Ischemic Limb

02/06/2019

Luis Angel Suarez Gonzalez

Pablo Del Canto Peruyera

Javier Cerviño Alvarez

Luis Javier Alvarez Fernandez

The authors present the case of a 68-year old man who smokes with a history of hypertension, diabetes, and dyslipidemia, who was referred to the vascular clinic with complaints of intermittent claudication and a developing ulcer on his heel.

The authors present the case of...

02/06/2019

Wounds

News

Combining Y90 Transarterial Radioembolization With Immunotherapy is Safe

09/09/2018

Yttrium-90 (90Y) transarterial radioembolization (TARE) around immunotherapy is safe and effective and the combined treatment may improve hepatic progression-free survival (hPFS) and overall survival (OS) in patients with hepatic metastases...

Yttrium-90 (90Y) transarterial...

09/09/2018

IO Learning

Case Report and Brief Review

Synergism of Therapies After Postoperative Autograft Failure in a Patient With Melanoma of the Foot Misdiagnosed as a Pressure Ulcer

04/12/2018

Agata Janowska

Teresa Oranges

Andrea Chiricozzi

Marco Romanelli

Valentina Dini

04/12/2018

Wounds

Quiz

Best Targeted Therapy for Melanoma

11/10/2016

JCP Editors

A study published in JAMA Oncology recently showed that treatment with which of the following drug types was just as effective as BRAF- and MEK-targeted therapies for melanoma and also limited the risk of...

A...

11/10/2016

Journal of Clinical Pathways

Research in Review

Surveillance Superior to Standard Care for Melanoma

11/01/2016

JCP Editors

Specialized surveillance may be more cost effective and lead to fewer invasive procedures compared with standard care for patients with a high risk of melanoma, according to a study published in the Journal of...

...

11/01/2016

Journal of Clinical Pathways

Research in Review

Ipilimumab Combination Significantly Improves Melanoma Outcomes

07/27/2016

JCP Editors

Ipilimumab (Yervoy; Bristol-Myers Squibb) combined with local peripheral treatments such as radiotherapy or electrochemotherapy may significantly prolong survival in patients with melanoma compared with...

...

07/27/2016

Journal of Clinical Pathways